Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00002188 | A Study of ALRT1057 in Patients With AIDS-Related Kaposi's Sarcoma | PHASE2 | COMPLETED | 27 | — | — | - | - | Jun 24, 2005 | - | — |
| Name | Type | Description |
|---|---|---|
| Alitretinoin | DRUG | - |
Inclusion Criteria Patients must have: * HIV positive status and histologic confirmation of KS. * CD4 count \> 200 mm3 (required of one-half of patients). * Minimum of 6 mucocutaneous KS lesions, including at least 3 raised lesions meeting criteria for "indicator" lesions. * Acceptable organ syste...